Impact of a universal monitoring system ("third party") on outcomes of ICD patients: A nationwide study.

Niraj Varma¹, Eloi Marijon², Éric Vicaut³, Serge Boveda⁴, Alexandre Abraham⁵, Issam Ibnouhsein⁵, Arnaud Rosier⁶, Pascal Defaye⁷, Jagmeet P Singh⁸

¹Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic London, London, United Kingdom. Electronic address: varman@ccf.org.

²Hôpital Européen Georges Pompidou, AP-HP, Paris, France.

³Unité de Recherche Clinique, Saint-Louis Lariboisière Fernand-Widal, AP-HP, Paris, France.

⁴Heart Rhythm Department, Clinique Pasteur, Toulouse, France; Brussels University VUB, Brussels, Belgium.

⁵Implicity, Paris, France.

⁶Implicity, Paris, France; Hôpital Privé Jacques Cartier, Massy, France.

⁷CHU Grenoble-Alpes, Grenoble, France.

⁸Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

PubMed DOI

Abstract

BACKGROUND: Adherence to recommended follow-up schedules for remote monitoring (RM) of patients with implantable cardioverter-defibrillators (ICDs) is inconsistent, which may influence clinical outcomes. Systematic organization through a "third-party" universal monitoring system (UMS) may be beneficial. OBJECTIVE: We aimed to evaluate the clinical impact of RM and any incremental benefit of UMS v…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.